Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Frenzel

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 4, 2018
Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancerAnastassia Löser, Burkhard Beyer, Cedric Oliver Carl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2016
Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [<sup>68</sup>Ga]PSMA I&T and comparison with published data of [<sup>68</sup>Ga]PSMA HBED-CCChristoph Berliner, Milena Tienken, Thorsten Frenzel, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 30, 2024
Current State and Outlook in Medical 3D Printing and the Role of RadiologyAnna Streckenbach, Niklas Schubert, Felix Streckenbach, et al.
The Journal of Clinical Investigation|February 3, 2026
Overexpression of the ERG oncogene in prostate cancer identifies candidates for PARP inhibitor-based radiosensitizationSabrina Köcher, Mohamed E Elsesy, Ayham Moustafa, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 4, 2018
Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancerAnastassia Löser, Burkhard Beyer, Cedric Oliver Carl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2016
Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [<sup>68</sup>Ga]PSMA I&T and comparison with published data of [<sup>68</sup>Ga]PSMA HBED-CCChristoph Berliner, Milena Tienken, Thorsten Frenzel, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 30, 2024
Current State and Outlook in Medical 3D Printing and the Role of RadiologyAnna Streckenbach, Niklas Schubert, Felix Streckenbach, et al.
The Journal of Clinical Investigation|February 3, 2026
Overexpression of the ERG oncogene in prostate cancer identifies candidates for PARP inhibitor-based radiosensitizationSabrina Köcher, Mohamed E Elsesy, Ayham Moustafa, et al.
Pageof 3